Vlad Țâru

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

CIRROXABAN Study is finally here!
🔬 First DB RCT evaluating rivaroxaban in cirrhosis
💡 Complication-free survival benefit in Child‑Pugh B7 (HR 0.26 [95 % CI 0.07–0.90]).
⚠️ Mild bleeding ↑, but no increase in severe events.
📄 https://t.co/KMjoBIZVsp

[Debbie Shawcross @DebbieShawcros1]

Congratulations to each and everyone of the @JHepatology and @JHEP_Reports team on behalf of @EASLnews
I am a very proud EASL Secretary General 🫶

[Salvatore Piano @salvatore_piano]

📣New data on cirrhosis recompensation in @JHepatology

✅Only 7% meets strict Baveno VII criteria
✅Expanded criteria capture ~38% with similar low mortality risk

Recompensation:
⬇️systemic inflammation🔥
👍 improved hemodynamic
⬆️improved survival

https://t.co/xPcE25dPcC

[Thomas Reiberger @ReibergerThomas]

@ViennaLiverNews @MedUni_Wien @EASLnews Congress #2025 in #Amsterdam

[EASLnews @EASLnews]

- 🌷🌷Final touches are underway as we get ready to welcome thousands of delegates to #EASLCongress 2025!

From vibrant session spaces to a packed scientific programme, the RAI Amsterdam is set to become a true hub for hepatology.

We can’t wait to open the doors and kick off an unforgettable week of discovery, collaboration and inspiration!

Don't forget to check the scientific programme: https://t.co/lyWzLrbYqA

Attending onsite? Download your badge from your confirmation email, print it in color at 100% size on A4 paper, and bring it with you to insert into the badge holder onsite.

We can't wait to see you soon on 7-10 May!

@AleksanderKrag @DebbieShawcros1 @analleo @RuiCastroHD

[EASLnews @EASLnews]

👩‍🔬👨‍🔬 Are you a young investigator at #EASLCongress 2025?

Don’t miss the YI sessions designed just for you — including the must-attend workshop:
“From Postdoc to PI” 🔬✨
Real stories, personal journeys, and honest discussions about the leap from postdoc to leading your own research group.
Who knows — your future collaborators might be in the room!

👉View the session: https://t.co/QXaE6aeqQv

@C_V_Schneider @EASLedu @tom_marjot @DraMartaAlonsoP

[Vlad Țâru @VladTaruMD]

Amazing achievement by our colleague, Dr. Benedikt Simbrunner #MD #PhD! Congrats 🥂

[Thomas Reiberger @ReibergerThomas]

Dr. Benedikt Simbrunner #MD #PhD of @MedUni_Wien received yesterday a very special honor:

🎓Promotio sub auspiciis Praesidentis rei publicae

🇦🇹#PhD Promotion with best possible grades throughout the career 🔗https://t.co/iKw24DSduQ

[Mattias Mandorfer @MattiasMandorf1]

@BavenoCoop Research Committee Baveno VIII Pre-Symposium, here we go!
👍 103 members watching online
👉 High interest in designing clinical studies on PH!
#LiverTwitter

[Vlad Țâru @VladTaruMD]

I am very thankful to the @EASLnews for providing us with the opportunity to present our translational research on #NSBBs in #ACLF and to our amazing team @ViennaLiverNews for continuos support and motivation!

[Thomas Reiberger @ReibergerThomas]

#LiverTwitter #Betablocker #NSBB

✅prevent🩸(re)bleeding @AGA_CGH
✅ameliorate🔥inflammation @Gut_BMJ
#Carvedilol improves survival @JHepatology

🧐#Safety monitoring in #decompensated cirrhosis is warranted

@TaruVlad will present #NSBB data in #ACLF @EASLnews #2025

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

And last but not least...

💡Uncover the methodological pitfalls in observational studies in Hepatology. Ensure your research is robust and reliable‼️

⏰ Just 1⃣ week to go!

🔗Register: https://t.co/fTLrHIZcIc
🗓️March 5, 2025
💰Free for members | €100 non-members 👇

[Vlad Țâru @VladTaruMD]

Many thanks @ViennaLiverNews
#LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2025 in Amsterdam, from 7-10 May. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩‍🔬 https://t.co/qQYnEga6aP @EASLNews

[MOTION Vienna @CrgMotion]

#twitterliver #PortalHypertension
WP1 focuses on the classical & alternative renin-angiotensin system as a disease-driving mechanism in patients with compensated advanced chronic liver disease & investigates potentially beneficial effects of telmisartan in this patient group.⬇️⬇️

[Thomas Reiberger @ReibergerThomas]

Happy XMas ❤️🎄🎅 and Happy 🆕 Year 2025✨
HEPEX 🥼#Liver #Fibrosis🧪Lab @MedUni_Wien

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

🎄 Wishing everyone a Merry Christmas and Happy Holidays from all of us at @BavenoCoop ‼️

✨ Here's to a joyful season and a 2025 filled with groundbreaking advancements for our patients—the heart of our profession 🧭🫂

👩‍🔬Thanks to all our colleagues for our shared mission‼️

[Eur. Fdn. for the Study of Chronic Liver Failure @ef_clif]

As we reflect on a year of collaboration and progress in understanding and treating #chronicliverdisease, we sincerely thank our partners and colleagues worldwide for their incredible support. Looking forward to a new year of discovery and impact!

[Thomas Reiberger @ReibergerThomas]

5Y evaluation of for our CD-Lab
@MedUni_Wien & @Boehringer for
#PortalHypertension & #LiverFibrosis.

🗝️achievements:
- investigation of #sGC signaling in liver disease
- established #fibrosis #regression models
- prognostic #biomarker
- #scRNAseq in #PSC

[Vlad Țâru @VladTaruMD]

#inflammasomes

The role of type 1 immune response via hepatic toll-like receptors (TLRs) & nucleotide-binding oligomerization domain-like (NLRs) :

♨️ inflammation
▶️ liver disease progression
💊 potential therapies

@JHepatology
https://t.co/ayuapQiXRu

[Thomas Reiberger @ReibergerThomas]

#Inflammasomes

How is a type 1 immune response to #DAMPs & #PAMPs connected to inflammasome signaling?

Lean how hepatic toll-like receptors &
nucleotide-binding oligomerization domain-like receptors (NLRs) drive liver disease

📕@JHepatology
https://t.co/mOSWb8fElP

[Thomas Reiberger @ReibergerThomas]

HEPEX Lab for #LiverFibrosis and #PortalHypertension @MedUni_Wien

@t_sorz Digital Histomorphometry & AI
@KathiBonitz Macrophage scSeq
@BenediktHofer ALD recompensation
@VladTaruMD Inflammasome #ACLF
@xander_petrenko omics #PSC #ECMatrix

[Vlad Țâru @VladTaruMD]

Our 🆕 REVIEW manuscript on #inflammasome mediated hepatic injury has been published in the prestigious @JHepatology !

🙏 Deeply thankful to the greatest:
@ReibergerThomas, @GSzaboMD, @WajahatMehal and @bogdanprocopet

#LiverTwitter @ViennaLiverNews @MedUni_Wien @LiReC_cluj

[Journal of Hepatology @JHepatology]

🆕REVIEW❕

Inflammasomes in chronic liver disease

➡️#HepaticInjury, #fibrosis progression and systemic inflammation

By @VladTaruMD, @GSzaboMD, Wajahat Mehal & @ReibergerThomas

#OpenAccess here👉https://t.co/1j8MmwfiJM

#LiverTwitter

[Vlad Țâru @VladTaruMD]

@ReibergerThomas @BenediktHofer @FrancqueSven @MattiasMandorf1 @MPraktiknjo @RafaelBanares @christianjansen @HeleneLarrue @MadalinaTaru and @bogdanprocopet 🙏🙏